TAKASHI MAKINODAN, Department of Veterans Affairs Medical Center, West Los Angeles, California

JOHN E. MORLEY, Department of Veterans Affairs Medical Center, Sepulveda, California

DIRECTORS, PHARMACEUTICAL COMPANY RESEARCH

WILLIAM ABRAMS, Executive Director, Scientific Development, Merck, Sharpe, and Dohme, Rahway, New Jersey

LIONEL EDWARDS, Director, Clinical Research, Schering-Plough, Kenilworth, New Jersey

ELKAN GAMZU, Senior Director, Drug Development, Parke Davis, Ann Arbor, Michigan

JAMES GAYLOR, Director, Molecular Biology, Johnson and Johnson Company, New Brunswick, New Jersey

JOHN GODFREY, Associate Director, Clinical Research, Rorer Central Research, Horsham, Pennsylvania

ROBERT LEWIS, Director, Basic Research, Syntex Corporation, Palo Alto, California

ERIC MUTH, Director, Central Nervous System Clinical Research, Wyeth Ayerst Research, Monmouth, New Jersey

RAJESH SHROTRIYA, Director, Central Nervous System Clinical Research, Bristol Myers Company, Wallingford, Connecticut

W. LEIGH THOMPSON, Group Vice President, Eli Lilly and Company, Indianapolis, Indiana

MICHAEL TIDD, Director, Medical Division, Norwich-Eaton Pharmaceuticals, Inc., Norwich, New York



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement